Alawode Oladele

Alawode Oladele, MD, MPH, (born 1964) is a Kellogg Emerging Leaders in Public Health Fellow (2004).
Founded in 2003 by the Kellogg Foundation and the University of North Carolina at Chapel Hill's Keenan-Flagler School of Business and the North Carolina Institute for Public Health, the Fellowship is a 10-month long leadership and management development program offered nationally to mid and senior level public health professionals in the Native American/American Indian, African American, and Latino communities. The mission of the Fellowship is to equip a cadre of talented minority leaders with the skills needed to lead and manage in times of crisis, focusing on communication skills, financial and human resources management competencies.
Oladele received his MD degree from Morehouse School of Medicine, his Masters of Public Health from Rollins School of Public Health at Emory University, and did his internship, residency and fellowship at Emory University School of Medicine in Atlanta, Georgia. This Phi Beta Kappa graduate of Morehouse is the nephew of the late Maynard Jackson, also a Morehouse graduate and first African American Mayor of the City of Atlanta.
Dr. Oladele is the CEO of Premiere International Health Care Inc. with several HIV projects in West Africa, East and Central Africa. In addition he works with numerous US based and international organizations including Physicians for Human Rights, the International Association of Physicians in AIDS Care, and the Global Initiative for the Advancement of Nutritional Therapy (An international non-profit organization). Dr. Oladele worked as a consultant for the Centers for Disease Control and Prevention in developing the United States National HIV Prevention Strategic Plan, 2000- 2005.
Some of his other areas of interests include working on social justice issues (including but not limited to: economic development; community development; environmental justice; human rights; education reform; human development; and social change). He has participated in numerous research projects and published articles concerning the role of nutrition in Cancer and HIV, the integration of traditional African medicine and modern medicine, Infectious diseases, Urologic Cancers, Sickle cell, and cultural competency. He is the inventor for a method of treatment and urinary bladder instillation for bladder cancer (assigned the United States Patent number 6,037,332).
In 2007, Dr. Oladele, president of the and the executive board of the organization formed the Andrew Young Global Health Institute. Launched during Andrew Young's 75th Birthday celebration, the Andrew Young Global Health Institute was established to fund research fellows and senior research investigators world wide.

Main Menu

See Also

Main Menu